[Cytostatic treatment with a combination of vincristine and ifosfamide].
D000328:Adult; D000368:Aged; D000477:Alkylating Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D000505:Alopecia / Q000139:chemically induced; D005069:Evaluation Studies as Topic; D005260:Female; D005500:Follow-Up Studies; D006417:Hematuria / Q000139:chemically induced; D006801:Humans; D008297:Male; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local; D009369:Neoplasms / Q000188:drug therapy*; D011115:Polyneuropathies / Q000139:chemically induced; D014750:Vincristine / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*
D000477:Alkylating Agents; D014750:Vincristine
Zytostatische Kombinationsbehandlung mit Vincristinsulfat und Ifosfamid.